Researchers introduced IMCBench, a benchmark for multimodal LLMs in medical conversations combining clinical images and patient profiles, finding Claude Opus 4.6 tops performance but no model ensures safety for malignant and rare conditions.

Updated: 6/30/2026 1 min read

IMCBench: A New Benchmark for Multimodal LLMs in Medical Conversations

What is IMCBench?

FAQ

What is IMCBench?

IMCBench is a benchmark for evaluating multimodal LLMs in medical conversations that combine clinical images and patient profiles.

How does Claude Opus 4.6 compare to GPT-5.2 on this benchmark?

Claude Opus 4.6 scored 3.61 vs GPT-5.2's 3.29, but both show safety drops in malignant cases.

Should MENA healthcare teams adopt these models now?

They can start piloting Claude Opus 4.6 for diagnostic support, but must monitor safety closely and avoid full reliance in critical cases.

Source: arXiv cs.AI

AI-assisted content, human-reviewed.